60
Dongbao Enterprise
600867.SS·SSETonghua CNFounded 19954,000 employees
Mid CappharmaPublicEndocrinology
Platform: Insulin Bio
Market Cap
$2B
All Drugs
2
Clinical Trials
3
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (600867.SS)
Loading 600867.SS stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Teratinib | 600-6057 | NDA/BLA | 1 | PD-L1 | LN | ||
| Elrazanubrutinib | 600-9012 | NDA/BLA | 2 | APOC3 | DravetFSGS |
SEC Filings & Financial Documents
SEC filings are not available for SSE-listed companies.
Dongbao Enterprise trades on SSE (CN). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (3)